|
|
Article: Change of prescription.
- Article from:
- Design Week
- Article date:
- January 21, 2000
CopyrightCOPYRIGHT 2000 Centaur Communications Limited. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The merger of Glaxo Wellcome and SmithKline Beecham could result in upheaval for design groups working on the companies' brands. Mike Exon looks at the possible side effects.
Like the merger of any two business giants, the one proposed by Glaxo Wellcome and SmithKline Beecham has left an air of uncertainty amongst its staff and suppliers. This anxiety could linger until the end of the year.
For designers, it seems things will either remain unchanged or there will be a complete overhaul. It is too soon to say, but any review of strategic interests or a restructure of core business is also likely to affect brands.
The creation of the combined ...